Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-11-30

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for donepezil hydrochloride filed by Rising Pharma Holdings, Inc., likely reflecting labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)